HIV Diagnosis Referral
Summary Most HIV diagnoses are made in general practice. Delivering a positive HIV result can be a difficult task for a health worker, particularly when it might be the first diagnosis they have made. Knowing the best way to deliver a result and accessing the resources and support available to both clinician and patient can […]
Long-Acting Injectable HIV Treatment Tool
Long-acting injectable treatment for HIV is now available in Australia. This quick-reference tool offers HIV s100 Prescribers and other healthcare practitioners guidance on patient suitability, side effects, and the treatment schedule, designed for collaborative decision-making with patients. Access the interactive tool for real-time patient assessments and an interactive injection schedule, or download the PDF for […]
HIV Testing Tool for Primary Healthcare
Two-page HIV testing tool for primary healthcare practitioners that provides information on discussing HIV testing and test results. This tool was developed with financial support from Gilead Sciences. The sponsor had no input into the content.
HIV s100 Prescriber Course & Update
Stay informed with ASHM’s dynamic library of news, sector updates, policy and advocacy work, and project updates. Explore our collection for the latest insights in HIV, BBV, and sexual and reproductive health to stay up-to-date in the field.
HIV Testing Tool for Primary Healthcare
Two-page HIV testing tool for primary healthcare practitioners that provides information on discussing HIV testing and test results. This tool was developed with financial support from Gilead Sciences. The sponsor had no input into the content.
Australian-first anal cancer screening guidelines for people living with HIV launched
4 March 2025 – Australia’s first national anal cancer screening guidelines for people living with HIV have been released, providing a critical framework around screening and treatment for healthcare providers. Globally, people living with HIV have the highest incidence rate of anal squamous cell carcinoma, the most common type of anal cancer. The guidelines, launched […]
Highlights from HIV&AIDS 2024 and the 25th IUSTI World Congress
In September 2024, ASHM delivered two landmark conferences at ICC Sydney on Gadigal Country: the Australasian HIV&AIDS Conference 2024 and 25th IUSTI World Congress (incorporating the Australasian Sexual and Reproductive Health Conference). Together, these conferences united over 1,200 delegates from 35 countries over 5 days to discuss the latest advancements in HIV and sexual and […]
HIV Unwrapped
HIV Unwrapped 2024: a re-imagination of the lab coat This project is based upon the exceptional work done in the CLOAK project by the University of Technology Sydney and University of Sydney last year as part of World Pride 2023. This project extends an invitation to consider: what would a HIV scientist/researcher wear which amplifies themselves and […]
Budget announcement marks major investment in HIV, BBVs and STIs
ASHM welcomes news from the federal budget of a $126.5 million investment over two years to support the prevention, testing and treatment of blood-borne viruses (BBVs) and STIs, alongside a $43.9 million investment to implement the recommendations of the HIV Taskforce. This announcement represents a significant investment by the federal government in the national response […]
Stigma and discrimination, no place in healthcare.
Stigma and discrimination, no place in healthcare. These resources serve as a guide and support for healthcare professionals seeking to understand and address the impact of stigma and discrimination on patient care. Our materials cover best practices for creating inclusive healthcare environments, identification and mitigation of bias, and relevant research and literature on the topic. […]
